KR20220034183A - 약제학적 제제 - Google Patents

약제학적 제제 Download PDF

Info

Publication number
KR20220034183A
KR20220034183A KR1020227004293A KR20227004293A KR20220034183A KR 20220034183 A KR20220034183 A KR 20220034183A KR 1020227004293 A KR1020227004293 A KR 1020227004293A KR 20227004293 A KR20227004293 A KR 20227004293A KR 20220034183 A KR20220034183 A KR 20220034183A
Authority
KR
South Korea
Prior art keywords
pharmaceutically acceptable
solid
solid formulation
formulation
benzonitrile
Prior art date
Application number
KR1020227004293A
Other languages
English (en)
Korean (ko)
Inventor
코린나 쇼흐
마르쿠스 릴
게로 호프
마르쿠스 클렘
카르슈텐 슈미트
마르쿠스 바이간트
Original Assignee
메르크 파텐트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메르크 파텐트 게엠베하 filed Critical 메르크 파텐트 게엠베하
Publication of KR20220034183A publication Critical patent/KR20220034183A/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020227004293A 2019-07-10 2020-07-08 약제학적 제제 KR20220034183A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19185500 2019-07-10
EP19185500.6 2019-07-10
PCT/EP2020/069165 WO2021005077A1 (en) 2019-07-10 2020-07-08 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
KR20220034183A true KR20220034183A (ko) 2022-03-17

Family

ID=67226151

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227004293A KR20220034183A (ko) 2019-07-10 2020-07-08 약제학적 제제

Country Status (21)

Country Link
US (1) US20220288068A1 (sr)
EP (2) EP4260910A3 (sr)
JP (1) JP2022540170A (sr)
KR (1) KR20220034183A (sr)
CN (1) CN114025761A (sr)
AU (1) AU2020309149A1 (sr)
BR (1) BR112022000266A2 (sr)
CA (1) CA3146384A1 (sr)
DK (1) DK3996688T3 (sr)
ES (1) ES2966788T3 (sr)
FI (1) FI3996688T3 (sr)
HR (1) HRP20231548T1 (sr)
HU (1) HUE064434T2 (sr)
IL (1) IL289481A (sr)
LT (1) LT3996688T (sr)
MX (1) MX2022000358A (sr)
PL (1) PL3996688T3 (sr)
PT (1) PT3996688T (sr)
RS (1) RS64906B1 (sr)
SI (1) SI3996688T1 (sr)
WO (1) WO2021005077A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919866A (zh) * 2022-12-07 2023-04-07 深圳海王医药科技研究院有限公司 特泊替尼固体分散体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007032507A1 (de) 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
EP2373640B1 (en) * 2009-01-08 2014-07-30 Merck Patent GmbH Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
DE102010035744A1 (de) 2010-08-28 2012-03-01 Merck Patent Gmbh Imidazolonylchinoline
JP6240658B2 (ja) * 2012-03-19 2017-11-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 抗がん活性を有する６−オキソ−１，６−ジヒドロ−ピリダジン誘導体と他の抗腫瘍化合物との組み合わせ
DK2914264T3 (en) * 2012-11-02 2017-09-11 Merck Patent Gmbh 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR USE FOR THE TREATMENT OF HEPATOCELLULAR CARCINOM (HCC)
JP2017502978A (ja) * 2014-01-07 2017-01-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 腎細胞癌（ｒｃｃ）の処置のための使用のための６−オキソ−１，６−ジヒドロ−ピリダジン誘導体

Also Published As

Publication number Publication date
PL3996688T3 (pl) 2024-02-12
EP3996688A1 (en) 2022-05-18
MX2022000358A (es) 2022-02-03
EP4260910A3 (en) 2023-12-27
HUE064434T2 (hu) 2024-03-28
CN114025761A (zh) 2022-02-08
US20220288068A1 (en) 2022-09-15
ES2966788T3 (es) 2024-04-24
DK3996688T3 (da) 2023-11-27
SI3996688T1 (sl) 2024-01-31
CA3146384A1 (en) 2021-01-14
WO2021005077A1 (en) 2021-01-14
AU2020309149A1 (en) 2022-03-03
BR112022000266A2 (pt) 2022-05-17
LT3996688T (lt) 2023-12-27
EP3996688B1 (en) 2023-09-06
RS64906B1 (sr) 2023-12-29
PT3996688T (pt) 2023-11-29
FI3996688T3 (fi) 2023-11-30
HRP20231548T1 (hr) 2024-03-15
JP2022540170A (ja) 2022-09-14
IL289481A (en) 2022-02-01
EP4260910A2 (en) 2023-10-18

Similar Documents

Publication Publication Date Title
JP6588915B2 (ja) Ａｚｄ９２９１を含む医薬組成物
JP5641682B2 (ja) 徐放性ナノ粒子組成物
JP4757872B2 (ja) プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用
EP2590630B1 (en) Oral dosage form of deferasirox
JP5351490B2 (ja) ニフェジピン含有有核錠剤およびその製法
AU2019232937B2 (en) Ceritinib formulation
CA2761212A1 (en) Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufacturing
KR20220034183A (ko) 약제학적 제제
WO2009043914A1 (en) Multi particulate matrix system containing galantamine
EP3511001B1 (en) Pirfenidone-containing tablet and capsule formulation
KR20220028097A (ko) 다롤루타미드의 약제학적 조성물
EP2044933A1 (en) Multi particulate matrix system containing galantamine
KR20150096787A (ko) Ｎ-[5-[2-(3,5-디메톡시페닐)에틸]-2ｈ-피라졸-3-일]-4-[(3ｒ,5ｓ)-3,5-디메틸피페라진-1-일]벤즈아미드의 약학 제제
WO2014016371A1 (en) Micronized aleglitazar
US20230119355A1 (en) Pharmaceutical compositions of a kinase inhibitor
WO2003080057A1 (fr) Comprime-noyau de taille reduite contenant de la nifedipine
EP3750527A1 (en) Stable tablet formulation of nifurtimox and process for producing the same
KR20090032085A (ko) 수용성이 불량한 활성 물질의 경구 투여용 약제학적 조성물
OA19661A (en) Tablets comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-YL) Pyridin-3-YL) Methoxy) Benzaldehyde.
TW200810759A (en) Oral pharmaceutical composition of a poorly water-soluble active substance
AU2007263016A1 (en) Oral pharmaceutical composition of a poorly water-soluble active substance